Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)

Perspective Therapeutics has disclosed Operating Leases across 8 years of filings, most recently posting $1.3 million for Q2 2026.

• In Q2 2026, Operating Leases rose 18.49% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $1.3 million (up 18.49% YoY), while the FY2025 annual figure was $1.0 million, down 29.62% from the prior year.
• Operating Leases came in at $1.3 million for Q2 2026 at Perspective Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.7 million in Q3 2024 to a low of $256000.0 in Q2 2022.
• Average Operating Leases over 5 years is $1.0 million, with a median of $1.0 million recorded in 2024.
• Year-over-year, Operating Leases tumbled 51.15% in 2022 and soared 242.58% in 2023.
• Over 5 years, Operating Leases stood at $458000.0 in 2022, then soared by 70.31% to $780000.0 in 2023, then surged by 83.08% to $1.4 million in 2024, then dropped by 29.62% to $1.0 million in 2025, then gained by 26.27% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $1.3 million in Q2 2026, $1.6 million in Q1 2026, and $1.0 million in Q4 2025.